Acute respiratory diseases: progression features, pharmaceutical therapy
Acute respiratory diseases (ARD) are widespread diseases and are of great social importance. Diagnosis of acute respiratory infections implies the damage to the respiratory system caused by a wide range of pathogens. Among the pathogens of acute respiratory infections are viruses of acute respirator...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-10-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2675 |
| id |
doaj-251d21f18da54a0eb5d84f6abcac18bc |
|---|---|
| record_format |
Article |
| spelling |
doaj-251d21f18da54a0eb5d84f6abcac18bc2021-07-28T13:29:38ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-10-01015828810.21518/2079-701X-2018-15-82-882627Acute respiratory diseases: progression features, pharmaceutical therapyN. V. Orlova0T. G. Suranova1Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Health of RussiaInstitute for Advanced Training of FMBA of RussiaAcute respiratory diseases (ARD) are widespread diseases and are of great social importance. Diagnosis of acute respiratory infections implies the damage to the respiratory system caused by a wide range of pathogens. Among the pathogens of acute respiratory infections are viruses of acute respiratory viral infection (ARVI) group, including influenza, as well as fungal and bacterial pathogens, which include intracellular bacteria: mycoplasma and chlamydia. Diseases caused by intracellular pathogens are treated by antibacterial drugs that can easily penetrate the cells and create there high concentrations.https://www.med-sovet.pro/jour/article/view/2675acute respiratory diseasesviral and bacterial pathogenspharmaceutical therapymacrolidesroxithromycin |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
N. V. Orlova T. G. Suranova |
| spellingShingle |
N. V. Orlova T. G. Suranova Acute respiratory diseases: progression features, pharmaceutical therapy Медицинский совет acute respiratory diseases viral and bacterial pathogens pharmaceutical therapy macrolides roxithromycin |
| author_facet |
N. V. Orlova T. G. Suranova |
| author_sort |
N. V. Orlova |
| title |
Acute respiratory diseases: progression features, pharmaceutical therapy |
| title_short |
Acute respiratory diseases: progression features, pharmaceutical therapy |
| title_full |
Acute respiratory diseases: progression features, pharmaceutical therapy |
| title_fullStr |
Acute respiratory diseases: progression features, pharmaceutical therapy |
| title_full_unstemmed |
Acute respiratory diseases: progression features, pharmaceutical therapy |
| title_sort |
acute respiratory diseases: progression features, pharmaceutical therapy |
| publisher |
Remedium Group LLC |
| series |
Медицинский совет |
| issn |
2079-701X 2658-5790 |
| publishDate |
2018-10-01 |
| description |
Acute respiratory diseases (ARD) are widespread diseases and are of great social importance. Diagnosis of acute respiratory infections implies the damage to the respiratory system caused by a wide range of pathogens. Among the pathogens of acute respiratory infections are viruses of acute respiratory viral infection (ARVI) group, including influenza, as well as fungal and bacterial pathogens, which include intracellular bacteria: mycoplasma and chlamydia. Diseases caused by intracellular pathogens are treated by antibacterial drugs that can easily penetrate the cells and create there high concentrations. |
| topic |
acute respiratory diseases viral and bacterial pathogens pharmaceutical therapy macrolides roxithromycin |
| url |
https://www.med-sovet.pro/jour/article/view/2675 |
| work_keys_str_mv |
AT nvorlova acuterespiratorydiseasesprogressionfeaturespharmaceuticaltherapy AT tgsuranova acuterespiratorydiseasesprogressionfeaturespharmaceuticaltherapy |
| _version_ |
1721273908488830976 |